IMAX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the data provided, IMAX Corp is not a strong buy for a beginner investor with a long-term strategy at this moment. While the company shows some positive growth trends, the recent financial performance, insider selling, and lack of strong trading signals suggest waiting for a better entry point.
The technical indicators are mixed. The MACD is negative and expanding downward, suggesting bearish momentum. RSI is neutral at 33.67, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is near its support level (S1: 38.758), with resistance at R1: 42.54. Overall, the technicals do not strongly indicate a buy at this time.
Analysts have recently raised price targets, with some maintaining Buy or Overweight ratings.
The company is benefiting from international expansion and premium cinema trends.
Strong Q4 revenue growth (+35.11% YoY) and gross margin improvement (+10.77% YoY).
Insider selling: CEO Richard Gelfond plans to sell shares worth $4.81 million.
Net income and EPS have dropped significantly (-87.99% and -90.00% YoY, respectively).
No significant hedge fund or insider trading activity to indicate strong institutional confidence.
Lack of strong proprietary trading signals (AI Stock Picker and SwingMax).
In Q4 2025, IMAX reported revenue growth of 35.11% YoY to $125.2M, driven by a 60%+ increase in box office and system installs. However, net income dropped by 87.99% YoY to $637K, and EPS fell by 90% YoY to $0.01. Gross margins improved to 55.96%, up 10.77% YoY, indicating operational efficiency despite declining profitability.
Recent analyst ratings are mixed. While some analysts have raised price targets (e.g., JPMorgan to $48, B. Riley to $46), others, like Goldman Sachs, maintain a Neutral rating. Analysts highlight IMAX's strong international expansion and premium cinema positioning but remain cautious about valuation and profitability.
